Literature DB >> 17566570

Do we need routine complete blood count following vaginal delivery?

Shir Dar1, Ilana Shoham Vardi, Gershon Holcberg, Haim Reuveni, Ronit Yerushalmi, Miriam Katz, Eyal Sheiner.   

Abstract

Routine post partum complete blood count examination (CBC) is customary in many medical centers. The rationale behind drawing a routine CBC is to estimate blood loss during delivery and to identify patients who will need blood transfusions. The present study was aimed to determine the necessity of routine post-partum CBC following vaginal delivery. A retrospective cohort study was performed including all patients who received blood transfusions following vaginal delivery between January 2003 and November 2004. Data were collected from birth files. The indications for administration of blood transfusions were noted. Of 20,694 vaginal deliveries, 0.7% (n = 138) received blood transfusions. All patients had at least one obstetric risk factor of postpartum hemorrhage or symptomatic anemia. None received the blood transfusion based upon postpartum CBC hemoglobin level alone. Routine postpartum CBC is not warranted for the purpose of identifying the patient in need of blood transfusions. Postpartum CBC should be performed when indicated according to risk factors for excessive blood loss or patients' complaints.

Entities:  

Mesh:

Year:  2006        PMID: 17566570

Source DB:  PubMed          Journal:  Int J Fertil Womens Med        ISSN: 1534-892X


  2 in total

1.  Undiagnosed abnormal postpartum blood loss: Incidence and risk factors.

Authors:  Aude Girault; Catherine Deneux-Tharaux; Loic Sentilhes; Françoise Maillard; François Goffinet
Journal:  PLoS One       Date:  2018-01-10       Impact factor: 3.240

2.  Evaluation of postpartum anaemia screening to improve anaemia diagnosis and patient care: A prospective non-randomized before-and-after anaemia screening protocol implementation study.

Authors:  Enav Yefet; Abeer Suleiman; Gali Garmi; Aliza Hatokay; Zohar Nachum
Journal:  Sci Rep       Date:  2019-05-24       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.